Evan B. Smith

522 total citations
13 papers, 379 citations indexed

About

Evan B. Smith is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Evan B. Smith has authored 13 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Oncology. Recurrent topics in Evan B. Smith's work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Evan B. Smith is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Evan B. Smith collaborates with scholars based in United States. Evan B. Smith's co-authors include Gregory S. Walker, Tim F. Ryder, Deepak Dalvie, R. Scott Obach, Haig Bozigian, Dimitri E. Grigoriadis, Raman Sharma, Tom Vidmar, Amy Freund and Amit S. Kalgutkar and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Chemical Research in Toxicology and Drug Metabolism and Disposition.

In The Last Decade

Evan B. Smith

13 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan B. Smith United States	12	139	120	68	64	53	13	379
Yoshiro Kohno Japan	11	98 0.7×	103 0.9×	91 1.3×	92 1.4×	32 0.6×	36	365
Mary E. Lame United States	10	224 1.6×	137 1.1×	51 0.8×	55 0.9×	138 2.6×	14	511
J L Ferrero United States	9	96 0.7×	146 1.2×	124 1.8×	69 1.1×	24 0.5×	11	434
William DeMaio United States	12	198 1.4×	81 0.7×	89 1.3×	47 0.7×	135 2.5×	20	493
Zbyněk Svoboda Czechia	14	123 0.9×	161 1.3×	100 1.5×	120 1.9×	67 1.3×	27	580
Keith Huie United States	13	165 1.2×	91 0.8×	88 1.3×	61 1.0×	34 0.6×	32	547
Toshio Suwa Japan	10	115 0.8×	55 0.5×	108 1.6×	61 1.0×	34 0.6×	42	378
J.R. Kiechel France	13	111 0.8×	182 1.5×	86 1.3×	92 1.4×	57 1.1×	27	516
Sonu Chand Thakur India	16	224 1.6×	56 0.5×	62 0.9×	62 1.0×	13 0.2×	41	614
Doo‐Man Oh United States	10	144 1.0×	63 0.5×	37 0.5×	188 2.9×	94 1.8×	13	645

Countries citing papers authored by Evan B. Smith

Since Specialization

Citations

This map shows the geographic impact of Evan B. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan B. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan B. Smith more than expected).

Fields of papers citing papers by Evan B. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan B. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan B. Smith. The network helps show where Evan B. Smith may publish in the future.

Co-authorship network of co-authors of Evan B. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Evan B. Smith. A scholar is included among the top collaborators of Evan B. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan B. Smith. Evan B. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Williams, John P., et al.. (2018). VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine). Progress in medicinal chemistry. 57(1). 87–111. 26 indexed citations

Skor, Heather, Evan B. Smith, Gordon Loewen, et al.. (2017). Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine. Drugs in R&D. 17(3). 449–459. 26 indexed citations

Walker, Gregory S., Jonathan Bauman, Tim F. Ryder, et al.. (2014). Biosynthesis of Drug Metabolites and Quantitation Using NMR Spectroscopy for Use in Pharmacologic and Drug Metabolism Studies. Drug Metabolism and Disposition. 42(10). 1627–1639. 41 indexed citations

Johnson, Theodore R., Weiwei Tan, Lance Goulet, et al.. (2014). Metabolism, excretion and pharmacokinetics of [¹⁴C]crizotinib following oral administration to healthy subjects. Xenobiotica. 45(1). 45–59. 45 indexed citations

Jamieson, Joseph, Evan B. Smith, Deepak Dalvie, Gregory J. Stevens, & Gina M. Yanochko. (2011). Myeloperoxidase-mediated bioactivation of 5-hydroxythiabendazole: A possible mechanism of thiabendazole toxicity. Toxicology in Vitro. 25(5). 1061–1066. 15 indexed citations

Walker, Gregory S., Tim F. Ryder, Raman Sharma, Evan B. Smith, & Amy Freund. (2010). Validation of Isolated Metabolites from Drug Metabolism Studies as Analytical Standards by Quantitative NMR. Drug Metabolism and Disposition. 39(3). 433–440. 47 indexed citations

Kalgutkar, Amit S., Deepak Dalvie, Jiri Aubrecht, et al.. (2007). Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation. Drug Metabolism and Disposition. 35(6). 848–858. 36 indexed citations

Zhao, Sabrina X., Deepak Dalvie, Joan M. Kelly, et al.. (2007). NADPH-Dependent Covalent Binding of [³H]Paroxetine to Human Liver Microsomes and S-9 Fractions: Identification of an Electrophilic Quinone Metabolite of Paroxetine. Chemical Research in Toxicology. 20(11). 1649–1657. 51 indexed citations

Hutzler, J. Matthew, Rick C. Steenwyk, Evan B. Smith, Gregory S. Walker, & Larry C. Wienkers. (2004). Mechanism-Based Inactivation of Cytochrome P450 2D6 by 1-[(2-Ethyl-4-methyl-1H-imidazol-5-yl)methyl]- 4-[4-(trifluoromethyl)-2-pyridinyl]piperazine: Kinetic Characterization and Evidence for Apoprotein Adduction. Chemical Research in Toxicology. 17(2). 174–184. 18 indexed citations

10.

Olson, S.C., et al.. (1998). In vitro metabolism of ceftiofur in bovine tissues. Journal of Veterinary Pharmacology and Therapeutics. 21(2). 112–120. 15 indexed citations

11.

Smith, Evan B., et al.. (1997). Metabolism of [¹⁴C]Ceftiofur Hydrochloride in Swine after Intramuscular Injections. Journal of Agricultural and Food Chemistry. 45(7). 2606–2611. 2 indexed citations

12.

Davison, K. L., Rex E. Hornish, Arthur L. Craigmill, et al.. (1995). [14C]Ceftiofur Sodium Absorption, Distribution, Metabolism, and Excretion in Sheep following Intramuscular Injections. Journal of Agricultural and Food Chemistry. 43(6). 1589–1597. 15 indexed citations

13.

Millérioux, L, et al.. (1995). Determination of ceftiofur and its desfuroylceftiofur-related metabolites in swine tissues by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 673(2). 231–244. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact